As previously reported, in October of 2023, the US International Trade Commission (ITC) ruled that certain pulse oximetry features of the Apple Watch infringed two of Masimo’s patents. Along with the infringement holding, the ITC issued a limited exclusion order, prohibiting the unlicensed entry of infringing Apple Watches into the United States. The Biden administration chose not to reverse the ITC’s decision, and Apple redesigned its watches in an attempt to circumvent the ban.
In January of this year, Apple submitted a Ruling Request to the US Customs and Border Protection in which it sought guidance as to whether modified versions of its watch still infringed the Masimo patents. The CBP handed down its ruling on January 12, holding that the newly modified watches did not infringe. Details of the watch re-design remained confidential, but a recently redacted version of the CBP’s ruling sheds light on how the re-design circumvents the ITC’s exclusion order. Specifically, a software change “prevent[s] the watch from engaging in any pulse oximetry functionality or measurement, (ii) prevent[s] the user from enabling any pulse oximetry functionality or measurement, including Blood Oxygen feature measurements or background measurements, and (iii) display[s] a screen indicating that the Blood Oxygen feature is unavailable[.]”
Written by Tanner Murphy
Associate, Caldwell
You may also like…
AstraZeneca challenges Axelpharm’s cancer drug patent
AstraZeneca is a world-renowned pharmaceutical company. It owns many patents in Russia and takes steps to protect them...
USPTO issues final rule on Director Review of PTAB decisions
On October 1, 2024, the USPTO published a new final rule, Rules Governing Director Review of Patent Trial and Appeal...
The dark side of fake goods: consumers put health, safety, and the economy at risk while fuelling organized crime
Organized crime groups take advantage of worldwide demand for low-priced goods, misleading consumers into purchasing...
Contact us to write for out Newsletter
